175 related articles for article (PubMed ID: 24603763)
1. Clonal expansion of the macrolide resistant ST386 within pneumococcal serotype 6C in France.
Janoir C; Cohen R; Levy C; Bingen E; Lepoutre A; Gutmann L; Varon E;
PLoS One; 2014; 9(3):e90935. PubMed ID: 24603763
[TBL] [Abstract][Full Text] [Related]
2. The Effect of 13-Valent Pneumococcal Conjugate Vaccine on the Serotype Distribution and Antibiotic Resistance Profiles in Children With Invasive Pneumococcal Disease.
Gaviria-Agudelo CL; Jordan-Villegas A; Garcia C; McCracken GH
J Pediatric Infect Dis Soc; 2017 Sep; 6(3):253-259. PubMed ID: 26907814
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of Streptococcus pneumoniae serogroup 6 isolates from IPD in children and adults in Germany.
van der Linden M; Winkel N; Küntzel S; Farkas A; Perniciaro SR; Reinert RR; Imöhl M
PLoS One; 2013; 8(4):e60848. PubMed ID: 23593324
[TBL] [Abstract][Full Text] [Related]
4. Rise of multidrug-resistant Streptococcus pneumoniae clones expressing non-vaccine serotypes among children following introduction of the 10-valent pneumococcal conjugate vaccine in Bulgaria.
Setchanova L; Alexandrova A; Pencheva D; Sirakov I; Mihova K; Kaneva R; Mitov I
J Glob Antimicrob Resist; 2018 Dec; 15():6-11. PubMed ID: 29803821
[TBL] [Abstract][Full Text] [Related]
5. Trends of invasive serotype 6C pneumococci in Spain: emergence of a new lineage.
Rolo D; Fenoll A; Ardanuy C; Calatayud L; Cubero M; de la Campa AG; Liñares J
J Antimicrob Chemother; 2011 Aug; 66(8):1712-8. PubMed ID: 21628304
[TBL] [Abstract][Full Text] [Related]
6. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.
Lepoutre A; Varon E; Georges S; Dorléans F; Janoir C; Gutmann L; Lévy-Bruhl D; ;
Vaccine; 2015 Jan; 33(2):359-66. PubMed ID: 25448105
[TBL] [Abstract][Full Text] [Related]
7. Population structure of Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil: emergence and expansion of the MDR serotype 6C-CC386 lineage.
Neves FPG; Cardoso NT; Souza ARV; Snyder RE; Marlow MM; Pinto TCA; Teixeira LM; Riley LW
J Antimicrob Chemother; 2018 May; 73(5):1206-1212. PubMed ID: 29401243
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
[TBL] [Abstract][Full Text] [Related]
9. Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance.
Grant LR; Hanquet G; Sepúlveda-Pachón IT; Theilacker C; Baay M; Slack MPE; Jodar L; Gessner BD
Vaccine; 2024 Apr; 42(12):2983-2993. PubMed ID: 38553292
[TBL] [Abstract][Full Text] [Related]
10. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
11. The rise and fall of pneumococcal serotypes carried in the PCV era.
Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018.
Andrews N; Kent A; Amin-Chowdhury Z; Sheppard C; Fry N; Ramsay M; Ladhani SN
Vaccine; 2019 Jul; 37(32):4491-4498. PubMed ID: 31272872
[TBL] [Abstract][Full Text] [Related]
13. Persistent Circulation of Vaccine Serotypes and Serotype Replacement After 5 Years of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine in the United Kingdom.
Kandasamy R; Voysey M; Collins S; Berbers G; Robinson H; Noel I; Hughes H; Ndimah S; Gould K; Fry N; Sheppard C; Ladhani S; Snape MD; Hinds J; Pollard AJ
J Infect Dis; 2020 Mar; 221(8):1361-1370. PubMed ID: 31004136
[TBL] [Abstract][Full Text] [Related]
14. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: The emergence of multidrug resistant serotype 6C.
Neves FPG; Cardoso NT; Snyder RE; Marlow MA; Cardoso CAA; Teixeira LM; Riley LW
Vaccine; 2017 May; 35(21):2794-2800. PubMed ID: 28431817
[TBL] [Abstract][Full Text] [Related]
16. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.
van der Linden M; Falkenhorst G; Perniciaro S; Imöhl M
PLoS One; 2015; 10(7):e0131494. PubMed ID: 26132078
[TBL] [Abstract][Full Text] [Related]
17. The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.
Cooper D; Yu X; Sidhu M; Nahm MH; Fernsten P; Jansen KU
Vaccine; 2011 Sep; 29(41):7207-11. PubMed ID: 21689707
[TBL] [Abstract][Full Text] [Related]
18. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
[TBL] [Abstract][Full Text] [Related]
19. Population Structure of Streptococcus pneumoniae Causing Invasive Disease in Adults in Portugal before PCV13 Availability for Adults: 2008-2011.
Horácio AN; Silva-Costa C; Diamantino-Miranda J; Lopes JP; Ramirez M; Melo-Cristino J;
PLoS One; 2016; 11(5):e0153602. PubMed ID: 27168156
[TBL] [Abstract][Full Text] [Related]
20. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period.
Okade H; Funatsu T; Eto M; Furuya Y; Mizunaga S; Nomura N; Mitsuyama J; Yamagishi Y; Mikamo H
J Infect Chemother; 2014 Jul; 20(7):423-8. PubMed ID: 24802765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
